1 Department of Medical Oncology, VU University Medical Center , Amsterdam, Netherlands .
2 Department of Pathology, VU University Medical Center , Amsterdam, Netherlands .
Hum Gene Ther. 2017 Sep;28(9):766-780. doi: 10.1089/hum.2016.143. Epub 2017 Jan 23.
Oncolytic adenoviruses represent a novel class of anticancer agents. Their efficacy in killing cancer cells is variable, suggesting that there is room for improvement. Host miRNAs have been shown to play important roles in susceptibility of cells to replication of different viruses. This study investigated if adenovirus replication in human prostate cancer cells is influenced by host cell miRNA expression. To this end, human miRNA expression in response to adenovirus infection was analyzed, and functional screens for lytic adenovirus replication were performed using synthetic miRNA mimic and inhibitor libraries. Adenovirus infection generally reduced miRNA expression. On top of this nonspecific interference with miRNA biogenesis, a set of miRNAs, including in particular miR-222, was found specifically reduced. Another set of miRNAs was found to promote adenovirus-induced death of prostate cancer cells. In most cases, this did not stimulate adenovirus propagation. The exception was miR-26b. Overexpression of miR-26b inhibited adenovirus-induced NF-κB activation, augmented adenovirus-mediated cell death, increased adenovirus progeny release, and promoted adenovirus propagation and spread in several human prostate cancer cell lines. This suggests that miR-26b is particularly useful to be combined with oncolytic adenovirus for more effective treatment of prostate cancer.
溶瘤腺病毒是一类新型的抗癌药物。它们在杀伤癌细胞方面的疗效各不相同,这表明还有改进的空间。宿主 microRNA 在细胞对不同病毒复制的易感性方面发挥着重要作用。本研究探讨了宿主细胞 microRNA 表达是否影响人前列腺癌细胞中腺病毒的复制。为此,分析了人 microRNA 对腺病毒感染的反应,并使用合成的 microRNA 模拟物和抑制剂文库进行了溶瘤腺病毒复制的功能筛选。腺病毒感染通常会降低 microRNA 的表达。除了对 microRNA 生物发生的这种非特异性干扰外,还发现了一组 microRNA,特别是 miR-222,特异性降低。还发现了另一组 microRNA 促进了前列腺癌细胞中腺病毒诱导的死亡。在大多数情况下,这并没有刺激腺病毒的繁殖。miR-26b 是个例外。miR-26b 的过表达抑制了腺病毒诱导的 NF-κB 激活,增强了腺病毒介导的细胞死亡,增加了腺病毒后代的释放,并促进了几种人前列腺癌细胞系中腺病毒的增殖和传播。这表明 miR-26b 特别适合与溶瘤腺病毒联合使用,以更有效地治疗前列腺癌。